Renal Denervation
13
2
3
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
7.7%
1 terminated out of 13 trials
85.7%
-0.8% vs benchmark
23%
3 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (13)
Renal Denervation in ADPKD- RDN-ADPKD Study
Renal Denervation in Chronic Kidney Disease - RDN-CKD Study
REnal Denervation After Stroke (REDs) Study - A Randomized Clinical Trial of Renal Denervation in the Subacute Phase of Stroke
Renal Arterial Denervation in Sympathetic Dysautonomia
Genetic Based Analysis in Hypertensive Patients
The Predictive Role of Proteomics in Blood Pressure Response of Hypertensive Patients Undergoing Renal Denervation.
Renal Denervation in Patients With Chronic Heart Failure With Preserved Ejection Fraction
Renal Nerves Stimulation Study
International First-in-Human Study of the EnligHTN Generation 2 System in Patients With Drug-resistant Uncontrolled Hypertension
Renal Denervation in Hypertension
Renal Denervation in Patients With Type 2 Diabetes Mellitus
Renal Denervation by Allegro System in Patients With Resistant Hypertension
Study of Catheter Based Renal Denervation Therapy in Hypertension